GTHX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - G1 Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.15 USD Market Closed

Market Cap: $377.2m

	G1 Therapeutics Inc NASDAQ:GTHX	US
	Marvel Discovery Corp XTSX:MARV	CA
C	Cognizant Technology Solutions Corp DUS:COZ	US
	Atex Resources Inc XTSX:ATX	CA
F	Fraser & Neave Holdings Bhd KLSE:F&N	MY
	Coty Inc NYSE:COTY	US
	Chunghwa Telecom Co Ltd TWSE:2412	TW
V	Veidekke ASA OSE:VEI	NO

Profitability Summary

G1 Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

92%

Declining Gross Margin

92% > 89%

Negative Operating Margin

-65%

Negative 3Y Average Operating Margin

-59%

Operating Margin is Increasing

-201% > -65%

Negative Net Margin

-77%

Negative 3Y Average Net Margin

-70%

Net Margin is Increasing

-220% > -77%

Negative Free Cash Flow Margin

-65%

Negative 3Y Average Free Cash Flow Margin

-56%

Free Cash Flow Margin is Increasing

-208% > -65%

Negative ROE

-109%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-137%

ROIC is Increasing

-362% > -112%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

92%

Declining Gross Margin

92% > 89%

Negative Operating Margin

-65%

Negative 3Y Average Operating Margin

-59%

Operating Margin is Increasing

-201% > -65%